Biomaterials for blood-contacting applications.

Consideration of biomaterials for blood-contacting applications should take into account blood-biomaterial interactions, factors influencing the blood response and evaluation procedures. Examination of blood-biomaterial interactions indicates that relevant features are protein adsorption, platelet reactions, intrinsic coagulation, fibrinolytic activity, erythrocytes, leucocytes and complement activation. Factors influencing the blood response to a biomaterial in clinical application are the biomaterial structure, the presence of an antithrombotic agent, the patient status as determined by the disease and drug therapy, and the nature of the application. Evaluation options for biomaterials are clinical, in vivo, ex vivo and in vitro, with ex vivo and in vitro procedures relevant for biomaterial development.

[1]  J. Mustard,et al.  Normal and abnormal haemostasis. , 1977, British medical bulletin.

[2]  E W Salzman,et al.  Protein-platelet interaction on heparinized surfaces. , 1969, Journal of biomedical materials research.

[3]  I A Feuerstein,et al.  Platelet transport and adhesion to reconstituted collagen and artificial surfaces,. , 1975, Transactions - American Society for Artificial Internal Organs.

[4]  C. Forbes,et al.  Thrombus formation and artificial surfaces. , 1978, British medical bulletin.

[5]  E. Grabowski,et al.  PLATELET ADHESION TO FOREIGN SURFACES UNDER CONTROLLED CONDITIONS OF WHOLE BLOOD FLOW: HUMAN VS RABBIT, DOG, CALF, SHEEP, PIG, MACAQUE, AND BABOON , 1977, Transactions - American Society for Artificial Internal Organs.

[6]  D. Falkenhagen,et al.  Clinical Relevance of Biocompatibility — The Material Cannot Be Divorced from the Device , 1987 .

[7]  D. Chapman,et al.  Biomembranes as models for polymer surfaces. II. The syntheses of reactive species for covalent coupling of phosphorylcholine to polymer surfaces. , 1986, Biomaterials.

[8]  P. Synek,et al.  Hydrophilized polyethylene catheters. , 1976, Journal of Biomedical Materials Research.

[9]  D. Chapman,et al.  Biomembranes as models for polymer surfaces. V. Thrombelastographic studies of polymeric lipids and polyesters. , 1989, Biomaterials.

[10]  Adams Ga,et al.  How much fibrinogen or fibronectin is enough for platelet adhesion , 1981 .

[11]  Cummings Rd,et al.  The effect of temperature on the interaction of platelets and leukocytes with materials exposed to flowing blood. , 1978 .

[12]  C. Clayton,et al.  Biomembranes as models for polymer surfaces. IV. ESCA analyses of a phosphorylcholine surface covalently bound to hydroxylated substrates. , 1986, Biomaterials.

[13]  A Watanabe,et al.  Interaction between phospholipids and biocompatible polymers containing a phosphorylcholine moiety. , 1991, Biomaterials.

[14]  J. Andrade,et al.  Panel conference. Blood-materials interactions - 20 years of frustration. , 1981, Transactions - American Society for Artificial Internal Organs.

[15]  U. Baurmeister,et al.  Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation. , 1987, Artificial organs.

[16]  J M Anderson,et al.  Protein adsorption from human plasma is reduced on phospholipid polymers. , 1991, Journal of biomedical materials research.

[17]  W. Zingg,et al.  Thermodynamic studies of cellular adhesion. , 1979, Transactions - American Society for Artificial Internal Organs.

[18]  L. Vroman,et al.  The complexity of blood at simple interfaces , 1978 .

[19]  Cazenave.  Blood Surface Interactions , 1986 .

[20]  G. Lowe,et al.  Biocompatibility of Cardiopulmonary Bypass: Influence on Blood Compatibility of Device Type, Mode of Blood Flow and Duration of Application , 1994, The International journal of artificial organs.

[21]  D. Gregonis,et al.  Retrieval and analysis of a clinical total artificial heart. , 1986, Journal of biomedical materials research.

[22]  N Nakabayashi,et al.  Reduced thrombogenicity of polymers having phospholipid polar groups. , 1990, Journal of biomedical materials research.

[23]  S. Cooper,et al.  Plasma Proteins: Their Role in Initiating Platelet and Fibrin Deposition on Biomaterials , 1982 .

[24]  Cummings Rd,et al.  Role of complement activation in cell adhesion to polymer blood contact surfaces. , 1980 .

[25]  S. Mohammad,et al.  Interactions of thrombin and antithrombin III with artificial surfaces. , 1979, Thrombosis research.

[26]  J. Niemetz.  Coagulant activity of leukocytes. Tissue factor activity. , 1972, The Journal of clinical investigation.

[27]  R. Albrecht,et al.  Platelet-protein interactions at blood-polymer interfaces in the canine test model. , 1983, Transactions - American Society for Artificial Internal Organs.

[28]  K. Ishihara,et al.  Improvement of blood compatibility on cellulose dialysis membrane. 2. Blood compatibility of phospholipid polymer grafted cellulose membrane. , 1992, Biomaterials.

[29]  H. Rieger.  Dependency of Platelet Aggregation (PA) in Vitro on Different Shear Rates , 1980, Thrombosis and Haemostasis.

[30]  Forbes Cd.  Thrombosis and artificial surfaces. , 1981 .

[31]  C. Patrono,et al.  Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. , 1980, Thrombosis research.

[32]  C. R. Blass,et al.  Biomaterials for Blood Tubing: The Application of Plasticised Poly(Vinyl Chloride) , 1992, The International journal of artificial organs.

[33]  E. Salzman,et al.  Elevated Plasma Fibrinopeptide A ana Thromboxane B2 Levels During Cardiopulmonary Bypass , 1980, Circulation.

[34]  H. Roberts,et al.  The Procoagulant Activity of Granulocytes 1 , 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  F. Grinnell,et al.  Deposition of fibronectin on material surfaces exposed to plasma: Quantitative and biological studies , 1983, Journal of cellular physiology.

[36]  T. Horbett,et al.  von Willebrand Factor/Factor VIII adsorption to surfaces from human plasma. , 1984, Thrombosis research.

[37]  J. Mustard,et al.  Platelet-surface reaction and thrombosis. , 1968, Surgery.

[38]  S Murabayashi,et al.  Biocompatibility: bioengineering aspects. , 1986, Artificial organs.

[39]  J. Mitchell,et al.  The Effect of White Cells on Platelet Aggregation , 1966, Thrombosis and Haemostasis.

[40]  S. D. Bruck.  On the evaluation of medical plastics in contact with blood. , 1982, Biomaterials.

[41]  B. Griffith,et al.  Infections and thromboembolism with implantable cardiovascular devices. , 1989, ASAIO transactions.

[42]  T. Horbett,et al.  Complement activation by hydroxyethylmethacrylate-ethylmethacrylate copolymers. , 1987, Journal of biomedical materials research.

[43]  D. Chenoweth,et al.  Complement activation produced by biomaterials. , 1986, Artificial organs.

[44]  D. F. Waugh,et al.  Thrombin adsorption and possible relations to thrombus formation. , 1969, Journal of biomedical materials research.

[45]  J. Feijen,et al.  Current Techniques to Improve the Blood Compatibility of Biomaterial Surfaces , 1991, The International journal of artificial organs.

[46]  M. Kazatchkine,et al.  Activation of the complement system at the interface between blood and artificial surfaces. , 1988, Biomaterials.

[47]  S. D. Bruck,et al.  Properties of Biomaterials in the Physiological Environment , 1980 .

[48]  R. Mason,et al.  The endothelium: roles in thrombosis and hemostasis. , 1977, Archives of pathology & laboratory medicine.

[49]  J. Feijen.  Thrombogenesis Caused by Blood-Foreign Surface Interaction , 1977 .

[50]  F. Grinnell,et al.  Adsorption characteristics of plasma fibronectin in relationship to biological activity. , 1981, Journal of biomedical materials research.

[51]  J M Courtney,et al.  Blood interactions with novel polyurethaneurea hydrogels. , 1991, Biomaterials.

[52]  L. Jennings,et al.  Ca2+-mediated association of glycoprotein G (thrombinsensitive protein, thrombospondin) with human platelets. , 1980, The Journal of biological chemistry.

[53]  L. Vroman,et al.  Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. , 1980, Blood.

[54]  R. Albrecht,et al.  Effect of thrombospondin and other platelet alpha-granule proteins on artificial surface-induced thrombosis. , 1982, Transactions - American Society for Artificial Internal Organs.

[55]  D. Chapman,et al.  Biomembranes as models for polymer surfaces. III. Characterization of a phosphorylcholine surface covalently bound to glass. , 1986, Biomaterials.

[56]  J M Courtney,et al.  Biomaterials in Medicine - A Bioengineering Perspective , 1993, The International journal of artificial organs.

[57]  S. Niewiarowski,et al.  Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets. , 1981, The Journal of biological chemistry.

[58]  R. Lerner,et al.  Changes in fibrinolytic activity during the course of a single hemodialysis session. , 1985, Clinical nephrology.

[59]  J. Griffin,et al.  Recent Advances in The Understanding of Contact Activation Reactions , 2008, Seminars in thrombosis and hemostasis.

[60]  M. Shuman,et al.  Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting. , 1980, The Journal of clinical investigation.

[61]  J. Courtney,et al.  Utilization of the platelet release reaction in the blood compatibility assessment of polymers. , 1984, Biomaterials.

[62]  H. Gurland,et al.  Ex vivo biocompatibility evaluation of a new modified cellulose membrane. , 1987, Artificial organs.